Test used must be approved by United States Food and Drug Administration; requirements for administration of test.

1. Any test for the human immunodeficiency virus, including, without limitation, a rapid test, that is used to carry out the provisions of NRS 442.600 to 442.660, inclusive, must be approved by the United States Food and Drug Administration. 2. Each test administered to a woman or performed on a child pursuant to the provisions of NRS 442.600 to 442.660, inclusive, must be administered or performed in accordance with: (a) The provisions of chapter 652 of NRS and any regulations adopted pursuant thereto; and (b) The Clinical Laboratory Improvement Amendments of 1988, Public Law No. 100-578, 42 U.S.C. § 263a, if applicable. (Added to NRS by 2007, 2367)